By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adamis Pharmaceuticals 

2658 Del Mar Heights Road
Suite 555
Del Mar  California  92014   U.S.A.
Phone: n/a Fax: n/a




Company News
Adamis Pharmaceuticals (ADMP) Announces Investor Update Live Webcast 6/13/2014 8:31:09 AM
Adamis Pharmaceuticals (ADMP) To Present At The 9th Annual JMP Securities Healthcare Conference 6/9/2014 9:23:06 AM
Adamis Pharmaceuticals (ADMP) CEO Dr. Dennis J. Carlo To Present At The LD Micro Invitational Conference Today 6/5/2014 9:41:32 AM
Adamis Pharmaceuticals (ADMP) New Drug Application To FDA For Its Epinephrine Pre-Filled Syringe 5/29/2014 10:08:18 AM
Adamis Pharmaceuticals Receives Notice Of Key Allowance For US Patent That Supports Its Cancer Immunology Portfolio 1/24/2014 9:03:52 AM
Adamis Pharmaceuticals Announces Full Exercise Of Underwriter's Over-Allotment Option 1/14/2014 9:23:32 AM
Adamis Pharmaceuticals Announces Completion Of Acquisition 1/8/2014 9:59:55 AM
Adamis Pharmaceuticals Announces Closing Of Public Offering Of Common Stock 12/19/2013 10:31:03 AM
Adamis Pharmaceuticals Announces Pricing Of Public Offering Of 3,720,000 Shares Of Common Stock, Listing On NASDAQ, Reverse Stock Split 12/16/2013 8:06:14 AM
Adamis Pharmaceuticals Announces Proposed Public Offering 11/21/2013 11:01:47 AM